
PBLA
Healthcare · Biotechnology · $970 market cap
$0.00020.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2024
EPS trend, 90 days to now · 30-day revisions 1 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 14, 2024 | Time not confirmed | -15.00 | -1.48 | +90.1% |
| Aug 13, 2024 | After the close | -1.69 | -1.47 | +13.0% |
| May 15, 2024 | After the close | -1.62 | -2.28 | -40.7% |
| Mar 26, 2024 | After the close | -24.34 | -65.90 | -170.7% |
| Nov 9, 2023 | After the close | -41.20 | -53.80 | -30.6% |
| Aug 10, 2023 | After the close | -94.10 | -159.00 | -69.0% |
| May 4, 2023 | After the close | -294.00 | -390.00 | -32.7% |
| Mar 16, 2023 | After the close | -3.70 | -5.68 | -53.5% |
| Nov 10, 2022 | After the close | -5520.01 | -5040.01 | +8.7% |
| Aug 15, 2022 | After the close | -6080.00 | -7255.21 | -19.3% |
| May 12, 2022 | After the close | -6120.01 | -6480.01 | -5.9% |
| Mar 24, 2022 | After the close | -7.20 | -10.40 | -44.4% |
| Nov 10, 2021 | After the close |
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The company's lead product candidates are Ivospemin (SBP-101), a proprietary polyamine analogue, which has completed Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma;…
| -5494.57 |
| -3840.00 |
| +30.1% |
| Aug 11, 2021 | After the close | -5160.01 | -5280.01 | -2.3% |
| May 12, 2021 | After the close | -3600.00 | -5520.01 | -53.3% |
| Mar 25, 2021 | After the close | -6.60 | -3.60 | +45.5% |
| Nov 12, 2020 | After the close | -2880.00 | -5040.01 | -75.0% |
| Aug 11, 2020 | Before the open | — | -0.06 | — |
| May 12, 2020 | After the close | — | -0.27 | — |
| Mar 24, 2020 | Before the open | — | -0.15 | — |
| Nov 13, 2019 | Before the open | — | -0.23 | — |
| Aug 13, 2019 | Before the open | — | -0.45 | — |
| May 14, 2019 | Before the open | — | -0.31 | — |
| Mar 22, 2019 | Before the open | — | -0.15 | — |
| Nov 5, 2018 | Before the open | — | -0.18 | — |
| Aug 13, 2018 | Time not confirmed | — | -0.54 | — |
| May 14, 2018 | Time not confirmed | — | -0.45 | — |
| Mar 21, 2018 | Time not confirmed | — | -0.58 | — |